Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bioallethrin is a synthetic type I pyrethroid insecticide and ectoparasiticide consisting of an approximately 1:1 mixture of two active allethrin stereoisomers. It is used principally in household insect-control products, including mosquito coils, vaporizing devices, aerosols, and other spatial-repellent or adulticide applications against mosquitoes, flies, cockroaches, and related pests. Its intended insecticidal action is modulation of insect voltage-gated sodium channels, causing abnormal neuronal excitation, paralysis, knockdown, and death; mosquito spatial repellency additionally involves olfactory signaling. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/Bioallethrin))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bioallethrin.